Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
Camenzind E., Wijns W., Mauri L., Kurowski V., Parikh K., Gao R., Bode C., Greenwood J.P., Boersma E., Vranckx P. et al., 2012. Lancet, 380 (9851) pp. 1396-1405.
ici le détail